Neuroendocrine neoplasms (NENs) are derived from neuroendocrine cell system and can
have benign or malignant characteristics. They are rare tumors, but have been increasing in …

Carcinoid syndrome (CS) develops in patients with hormone‐producing neuroendocrine
neoplasms (NENs) when hormones reach a significant level in the systemic circulation. The …

This manuscript is the result of the North American Neuroendocrine Tumor Society
consensus conference on the surgical management of pancreatic neuroendocrine tumors …

1. MATERIALS AND METHODS Data regarding the diagnosis, management, and follow‐up
of carcinoid syndrome (CS) and carcinoid heart disease (CHD) were identified by searches …

Carcinoid syndrome (CS) is a debilitating disease that affects approximately 20% of patients
with neuroendocrine neoplasms (NEN). Due to the increasing incidence and improved …

Carcinoid syndrome (CS) is a paraneoplastic syndrome caused by the release of serotonin
and other substances from well-differentiated neuroendocrine tumors (NETs). The hallmark …

Pancreatic neuroendocrine tumors (PNETs) are a heterogeneous and orphan group of
neoplasms that vary in their histology, clinical features, prognosis, and management. The …

Simple Summary Intraoperative carcinoid crisis (CC) is thought to be a potentially lethal
complication for patients with neuroendocrine tumors (NET). Though perioperative …

OBJECTIVE. The purpose of this article is to enhance knowledge of the clinical
implementation of peptide receptor radionuclide therapy (PRRT) and its impact on care of …

Neuroendocrine tumors (NETs) are a group of heterogeneous neoplasms arising from cells
of the neuroendocrine system. The term neuroendocrine neoplasia encompasses both well …